"We have made important advances in Alzheimer’s disease, Multiple Sclerosis (MS) and COVID testing and with our platform in Q3’2020 delivering another strong quarter of growth, despite continued headwinds associated with the pandemic," said Kevin Hrusovsky, Chairman, Chief Executive Officer, President, Quanterix. Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the three months ending September 30, 2020. GAAP revenue including one-time License and Grant revenue $31.4M Non-GAAP revenue $18.3M, an increase of 22% versus prior year
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |